Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgical Procedures | 3 | 2021 | 299 | 0.900 |
Why?
|
| Craniosynostoses | 2 | 2023 | 131 | 0.750 |
Why?
|
| Muscle Spasticity | 1 | 2021 | 73 | 0.730 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 80 | 0.680 |
Why?
|
| Syringomyelia | 1 | 2019 | 17 | 0.660 |
Why?
|
| Dystonia | 1 | 2021 | 172 | 0.650 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2019 | 51 | 0.630 |
Why?
|
| Spinal Stenosis | 4 | 2018 | 9 | 0.610 |
Why?
|
| Intracranial Hypertension | 1 | 2019 | 120 | 0.600 |
Why?
|
| Lumbar Vertebrae | 4 | 2018 | 109 | 0.580 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 623 | 0.570 |
Why?
|
| Decompression, Surgical | 5 | 2019 | 92 | 0.520 |
Why?
|
| Primary Health Care | 1 | 2021 | 754 | 0.480 |
Why?
|
| Hydrocephalus | 3 | 2025 | 242 | 0.450 |
Why?
|
| Lumbosacral Region | 4 | 2018 | 33 | 0.380 |
Why?
|
| Neurosurgery | 1 | 2012 | 76 | 0.370 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2025 | 79 | 0.350 |
Why?
|
| Spinal Dysraphism | 1 | 2012 | 265 | 0.300 |
Why?
|
| Meningomyelocele | 2 | 2024 | 235 | 0.300 |
Why?
|
| Barium | 1 | 2025 | 17 | 0.240 |
Why?
|
| Back Pain | 3 | 2018 | 27 | 0.230 |
Why?
|
| Laparotomy | 1 | 2024 | 135 | 0.220 |
Why?
|
| Hysterotomy | 1 | 2024 | 126 | 0.220 |
Why?
|
| Cerebral Revascularization | 1 | 2023 | 21 | 0.210 |
Why?
|
| Arteriovenous Fistula | 1 | 2023 | 56 | 0.210 |
Why?
|
| Moyamoya Disease | 1 | 2023 | 38 | 0.210 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2022 | 28 | 0.210 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 10 | 0.200 |
Why?
|
| Child | 12 | 2025 | 24256 | 0.200 |
Why?
|
| Vascular Malformations | 1 | 2022 | 81 | 0.190 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 226 | 0.180 |
Why?
|
| Medicaid | 1 | 2023 | 244 | 0.180 |
Why?
|
| Fetoscopy | 1 | 2024 | 439 | 0.170 |
Why?
|
| Humans | 23 | 2025 | 123262 | 0.170 |
Why?
|
| Asymptomatic Diseases | 1 | 2019 | 78 | 0.160 |
Why?
|
| Glioma | 2 | 2017 | 496 | 0.160 |
Why?
|
| Retrospective Studies | 9 | 2025 | 16069 | 0.160 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 404 | 0.160 |
Why?
|
| Thrombosis | 1 | 2023 | 518 | 0.160 |
Why?
|
| Neurosurgeons | 1 | 2018 | 11 | 0.160 |
Why?
|
| International Educational Exchange | 1 | 2018 | 17 | 0.150 |
Why?
|
| Alkylating Agents | 1 | 2017 | 11 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2021 | 546 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 2058 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 180 | 0.140 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2016 | 49 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 437 | 0.130 |
Why?
|
| Infant | 6 | 2024 | 12376 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 160 | 0.130 |
Why?
|
| Patient Selection | 1 | 2019 | 683 | 0.130 |
Why?
|
| Stroke | 1 | 2023 | 958 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 442 | 0.120 |
Why?
|
| Medicare | 1 | 2018 | 425 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 5056 | 0.120 |
Why?
|
| Treatment Outcome | 9 | 2024 | 12170 | 0.120 |
Why?
|
| Infratentorial Neoplasms | 1 | 2013 | 33 | 0.110 |
Why?
|
| Disease Management | 1 | 2016 | 515 | 0.100 |
Why?
|
| Choroid Plexus | 1 | 2012 | 23 | 0.100 |
Why?
|
| History, 17th Century | 1 | 2012 | 35 | 0.100 |
Why?
|
| History, 18th Century | 1 | 2012 | 69 | 0.100 |
Why?
|
| Incidence | 1 | 2019 | 3054 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2012 | 116 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2017 | 657 | 0.100 |
Why?
|
| Cysts | 1 | 2012 | 100 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2017 | 1553 | 0.090 |
Why?
|
| Epilepsy | 1 | 2018 | 858 | 0.090 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2010 | 23 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2013 | 471 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2025 | 13918 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2012 | 381 | 0.090 |
Why?
|
| Dacarbazine | 1 | 2010 | 86 | 0.090 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2010 | 99 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 3549 | 0.080 |
Why?
|
| Male | 12 | 2025 | 60334 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2012 | 298 | 0.080 |
Why?
|
| Basement Membrane | 1 | 2009 | 46 | 0.080 |
Why?
|
| Laminin | 1 | 2009 | 60 | 0.080 |
Why?
|
| Female | 12 | 2025 | 65618 | 0.080 |
Why?
|
| Nanostructures | 1 | 2009 | 52 | 0.080 |
Why?
|
| Gestational Age | 2 | 2024 | 1137 | 0.070 |
Why?
|
| Spinal Fusion | 2 | 2018 | 107 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3020 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2023 | 4701 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 713 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 668 | 0.070 |
Why?
|
| Obesity | 1 | 2017 | 2235 | 0.060 |
Why?
|
| Mitochondria | 1 | 2010 | 676 | 0.060 |
Why?
|
| Adolescent | 5 | 2025 | 19127 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2025 | 122 | 0.060 |
Why?
|
| Catheters | 1 | 2025 | 89 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2023 | 102 | 0.050 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2022 | 5 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2022 | 30 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 202 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 208 | 0.050 |
Why?
|
| Brain Stem | 1 | 2022 | 115 | 0.050 |
Why?
|
| Endoscopy | 1 | 2023 | 282 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2023 | 294 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2023 | 195 | 0.050 |
Why?
|
| United States | 3 | 2023 | 10654 | 0.050 |
Why?
|
| Adult | 5 | 2018 | 29100 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8114 | 0.040 |
Why?
|
| Aged | 4 | 2018 | 19198 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 352 | 0.040 |
Why?
|
| Quality of Life | 2 | 2018 | 1933 | 0.040 |
Why?
|
| Vietnam | 1 | 2018 | 44 | 0.040 |
Why?
|
| Middle Aged | 4 | 2018 | 26091 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 3677 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3239 | 0.040 |
Why?
|
| Program Development | 1 | 2018 | 187 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2018 | 191 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2018 | 138 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 164 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2018 | 358 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2017 | 85 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 137 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 240 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2017 | 135 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 141 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 424 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 819 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1473 | 0.030 |
Why?
|
| General Surgery | 1 | 2017 | 203 | 0.030 |
Why?
|
| Inpatients | 1 | 2018 | 494 | 0.030 |
Why?
|
| Ependyma | 1 | 2013 | 7 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1171 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1239 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 1290 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2012 | 14 | 0.030 |
Why?
|
| Medical Records | 1 | 2013 | 190 | 0.030 |
Why?
|
| Canada | 1 | 2013 | 293 | 0.030 |
Why?
|
| Edema | 1 | 2013 | 136 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 2966 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 10035 | 0.020 |
Why?
|
| Pregnancy | 1 | 2024 | 7129 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2012 | 125 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 254 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 1245 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 369 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 307 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2009 | 26 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2010 | 211 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2009 | 24 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 5767 | 0.020 |
Why?
|
| Neurites | 1 | 2009 | 44 | 0.020 |
Why?
|
| Culture Media | 1 | 2009 | 183 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6030 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2114 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 513 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2811 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2030 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6392 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2009 | 465 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 2854 | 0.010 |
Why?
|
| Stem Cells | 1 | 2009 | 701 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3336 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1787 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 3289 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 8867 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3666 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 33852 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 17556 | 0.010 |
Why?
|